Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Paradigm Biopharmaceuticals Ltd. announced that Dr. Donna Skerrett has stepped down from her role as Executive Director but will continue as Chief Medical Officer, focusing on the company’s phase 3 clinical program and upcoming New Drug Application. Dr. Skerrett’s leadership has been pivotal in advancing Paradigm’s strategic initiatives, and her continued involvement is expected to bolster the company’s efforts in bringing innovative therapies to market. This development underscores Paradigm’s commitment to achieving its strategic goals in drug development.
For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.